11-5226619-C-G
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PM5PP3_StrongPP5_Moderate
The NM_000518.5(HBB):āc.273G>Cā(p.Glu91Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000547 in 1,461,876 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E91K) has been classified as Pathogenic.
Frequency
Consequence
NM_000518.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HBB | NM_000518.5 | c.273G>C | p.Glu91Asp | missense_variant | 2/3 | ENST00000335295.4 | NP_000509.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HBB | ENST00000335295.4 | c.273G>C | p.Glu91Asp | missense_variant | 2/3 | 1 | NM_000518.5 | ENSP00000333994.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461876Hom.: 0 Cov.: 36 AF XY: 0.00000550 AC XY: 4AN XY: 727244
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hemoglobinopathy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Sep 06, 2023 | Variant summary: HBB c.273G>C (p.Glu91Asp) results in a conservative amino acid change located in the Globin domain (IPR000971) of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant was absent in 251422 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. This amino acid change (also known as Pierre-Benite or beta Glu90Asp) can be caused by c.273G>T as well as c.273G>C and is known as a high oxygen affinity hemoglobin variant that has been reported in the literature in heterozygous individuals affected with erythrocytosis/polycythaemia (example, Baklouti_1988, Beard_2001, Percy_2009, Oliviera_2018). These data indicate that the variant is very likely to be associated with dominant familial erythrocytosis while not providing unequivocal conclusions about association of the variant with Beta Thalassemia or a Hemglobinopathy. To our knowledge, no homozygous or compound heterozygous occurrence of the variant with pathogenic HBB variants have been reported. At least one publication reports experimental evidence evaluating a sample from a heterozygous patient, finding indication of increased oxygen affinity (Beard_2001). The following publications have been ascertained in the context of this evaluation (PMID: 19734427, 11843890, 3384709, 29790589). One submitter has provided an entry for this variant to ClinVar after 2014 without a clinical significance assessment. Based on the evidence outlined above, the variant was classified as pathogenic. - |
HEMOGLOBIN PIERRE-BENITE Other:1
other, no assertion criteria provided | literature only | OMIM | Dec 12, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at